CRISPR-Cas9 as a Tool in Cancer Therapy

Area of Science:

• Molecular Biology
• Genetics
• Biotechnology

Background:

• CRISPR-Cas9, a bacterial adaptive immunity system, has been repurposed as a powerful tool for precise DNA manipulation.
• Its simplicity and reliability have led to widespread adoption in biological research and cancer studies.
• CRISPR-Cas9 enables targeted modifications of genomic DNA with high accuracy, surpassing previous technologies in ease of use.

Purpose of the Study:

• To summarize strategies for developing CRISPR-Cas9-based therapeutic tools for cancer therapy.
• To review current clinical trials investigating the therapeutic potential of CRISPR-Cas9.

Main Methods:

• Review of existing scientific literature and clinical trial data.
• Analysis of CRISPR-Cas9 applications in cancer research models and immunotherapy.

Main Results:

• CRISPR-Cas9 facilitates the creation of models for studying carcinogenesis and drug testing.
• It is applied in immunotherapy through ex vivo genetic modification of patient T-cells.
• Several clinical trials are underway to validate its therapeutic efficacy.

Conclusions:

• CRISPR-Cas9 is vital for fundamental research, especially in understanding gene functions in carcinogenesis.
• Optimization of efficacy, safety, and specificity is essential before widespread clinical implementation.
• CRISPR-Cas9 holds significant promise for future cancer therapies.